- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Intellipharmaceutics International Inc.
Headquarters: Toronto, ON, Canada
Website: http://www.intellipharmaceu...
Year Founded: 1998
Status: Public
Industry Sector: HealthTechnology
CEO: Isa Odidi, PhD, MBA
Number Of Employees: N/A
Enterprise Value: N/A
PE Ratio: 0
Exchange/Ticker 1: OTCQB:IPCIF
Exchange/Ticker 2: TSX:IPCI
Latest Market Cap: N/A
BioCentury | Feb 1, 2020
Product Development
Any chance left for safer opioids?
Chances for safer opioids have nosedived with recent FDA and payer track records
BioCentury | Jan 14, 2020
Company News
Amid need for new pain options, FDA panel rebuffs Nektar’s ‘safer’ opioid
BioCentury | Sep 4, 2019
Company News
Sept. 4 Company Quick Takes: Boehringer licenses Lupin MEK inhibitor; plus BMS-BioMotiv, KemPharm-GPC, Lilly, Nektar and Intellipharmaceutics
BioCentury | Jul 28, 2017
Clinical News
Panel rejects Intellipharmaceutics' Rexista abuse deterrence claims
Items per page:
1 - 10 of 39